Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Peretz

Showing results (91-100 of 110) with videos related to

Pageof 11
Sort By:
Acta Oncologica (Stockholm, Sweden)|January 1, 1994
Clinical studies of liposome-encapsulated doxorubicinA Gabizon, R Isacson, E Libson, et al.
British Journal of Cancer|February 19, 2004
Interleukin-2 improves tumour response to DNP-modified autologous vaccine for the treatment of metastatic malignant melanomaM Lotem, E Shiloni, I Pappo, et al.
Prenatal Diagnosis|February 28, 2009
Preimplantation genetic diagnosis for BRCA1/2--a novel clinical experienceM Sagi, N Weinberg, A Eilat, et al.
Protein Expression and Purification|March 9, 2004
Production and purification of melanoma gp100 antigen and polyclonal antibodiesY Gelbart, S Frankenburg, Y Pinchasov, et al.
British Journal of Cancer|July 5, 2001
CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriersL Kadouri, D F Easton, S Edwards, et al.
Tissue Antigens|June 8, 2011
HLA-B35 correlates with a favorable outcome following adjuvant administration of an HLA-matched allogeneic melanoma vaccineM Lotem, L Kadouri, S Merims, et al.
British Journal of Cancer|June 27, 2002
Autologous cell vaccine as a post operative adjuvant treatment for high-risk melanoma patients (AJCC stages III and IV). The new American Joint Committee on CancerM Lotem, T Peretz, O Drize, et al.
Nature Medicine|July 8, 1999
Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasisI Vlodavsky, Y Friedmann, M Elkin, et al.
British Journal of Cancer|February 24, 2006
Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patientsA Nissan, D Jager, M Roystacher, et al.
Oncogene|September 19, 2012
EZH2 promotes a bi-lineage identity in basal-like breast cancer cellsR Z Granit, Y Gabai, T Hadar, et al.
Pageof 11

Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
Acta Oncologica (Stockholm, Sweden)|January 1, 1994
Clinical studies of liposome-encapsulated doxorubicinA Gabizon, R Isacson, E Libson, et al.
British Journal of Cancer|February 19, 2004
Interleukin-2 improves tumour response to DNP-modified autologous vaccine for the treatment of metastatic malignant melanomaM Lotem, E Shiloni, I Pappo, et al.
Prenatal Diagnosis|February 28, 2009
Preimplantation genetic diagnosis for BRCA1/2--a novel clinical experienceM Sagi, N Weinberg, A Eilat, et al.
Protein Expression and Purification|March 9, 2004
Production and purification of melanoma gp100 antigen and polyclonal antibodiesY Gelbart, S Frankenburg, Y Pinchasov, et al.
British Journal of Cancer|July 5, 2001
CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriersL Kadouri, D F Easton, S Edwards, et al.
Tissue Antigens|June 8, 2011
HLA-B35 correlates with a favorable outcome following adjuvant administration of an HLA-matched allogeneic melanoma vaccineM Lotem, L Kadouri, S Merims, et al.
British Journal of Cancer|June 27, 2002
Autologous cell vaccine as a post operative adjuvant treatment for high-risk melanoma patients (AJCC stages III and IV). The new American Joint Committee on CancerM Lotem, T Peretz, O Drize, et al.
Nature Medicine|July 8, 1999
Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasisI Vlodavsky, Y Friedmann, M Elkin, et al.
British Journal of Cancer|February 24, 2006
Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patientsA Nissan, D Jager, M Roystacher, et al.
Oncogene|September 19, 2012
EZH2 promotes a bi-lineage identity in basal-like breast cancer cellsR Z Granit, Y Gabai, T Hadar, et al.
Pageof 11